Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer
Antje Neeb, Ines Figueiredo, Bora Gurel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2021
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies
Yi Liang, Sujeeve Jeganathan, Stefano Marastoni, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
European Urology
|
July 13, 2020
Elucidating Durable Responses to Immune Checkpoint Inhibition
Pasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors
Sophie Archer, Phillip M Brailey, Minjung Song, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Cancer Research
|
October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Marta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Alistair Ring, Lucy S Kilburn, Alex Pearson, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer
Antje Neeb, Ines Figueiredo, Bora Gurel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2021
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies
Yi Liang, Sujeeve Jeganathan, Stefano Marastoni, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
The Prostate
|
January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial
Danyelle A Winchester, Bora Gurel, Cathee Till, et al.
European Urology
|
July 13, 2020
Elucidating Durable Responses to Immune Checkpoint Inhibition
Pasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors
Sophie Archer, Phillip M Brailey, Minjung Song, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Cancer Research
|
October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Marta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Alistair Ring, Lucy S Kilburn, Alex Pearson, et al.
Page
of 8